Delivery Order SPE2DB22D2211-SPE2DB25FSGER
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $108,836.00 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on September 15, 2025. This firm fixed-price contract, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Mounjaro is a tirzepatide-based...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,326.70 on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 29, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $4,932.91 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors with a completion date of September 12, 2025. This competitively awarded, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing one component of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,855.50 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price, non-set-aside delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a $16,662.76 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation. Mounjaro (tirzepatide) is...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $4,897.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a prescription diabetes medication used for glycemic control in patients...
- The Defense Logistics Agency awarded a delivery order valued at $1,573.21 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...